AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

Delivering the Latest Research and Best Practices from Around the World

AsiaTides 2010(寡核酸与肽治疗诊断相关研讨会)

2010年2月22日-24日,日本东京 Sheraton Miyako Hotel

Event Overview

有关新产品的开发与产品线的扩展，对于利用RNA干扰(RNAi)、适体、微型DNA、寡核苷酸、缩氨酸的治疗法的研究是不可或缺的

Choose your language

Delivering the Latest Research and Best Practices from Around the World

Conference Tutorials:

Analysis and Bioanalysis of Oligonucleotides in Support of Drug Development
RNA/DNA Synthesis and Purification: From Research to Commercial Scale

Conference Sessions:

RNAi Lead Generation and Preclinical Development
Updates on Oligo-Based Therapeutics in Clinical and Preclinical Development
Peptide-Based Therapeutics in Preclinical and Clinical Development
Peptide Vaccines
Diagnostics in Development
Delivery: Challenges and Solutions for Oligo and Peptide Therapeutics
Market Landscape: Intellectual Property
Innovation Showcase
Regulatory Updates

Network with Event More Colleagues:

Co-located with:

Innovation in Japan - Is It Still Alive?
Next Generation Biologics
Personalized Medicine and Biomarker Strategies in Drug Development
Developments in Stem Cell Science and Therapeutic Applications
Molecularly Targeted Cancer Therapies as a New Paradigm in Cancer Drug Development

» More information on this event

Network with Event More Colleagues:

Tides 2010

2010年4月25～28日
麻塞诸塞州波士顿

» More information on this event

AsiaTIDES是在日本运用寡核苷酸与缩氨酸之治疗法与诊断法的领域中唯一将焦点集中在研究、技术/制品开发、制造、合作上的学术会议。
在会期中，将有来自世界各地最尖端研究机构的研究人员，针对药物递送及处方的新方法、目前开发中的化合物、从制药业界与学术研究机关双方的观点来看商业化之最有效策略等主题发表最新的研究成果。

将有助于今后的研究开发：
RNA及缩氨酸关连的最新技术
• 将有来自北美与欧洲的领导尖端科技企业代表人前来发表有关药物递送与处方的新方法

将有助于研究开发之确切评估：
RNA及缩氨酸医药的最新情报
• 藉由聆听来自北美的37位演讲者与来自欧洲的7位演讲者的演讲，将能够掌握其他企业的动向，从各种个案研究与成功案例中学得教训

有助于发展开发计画、扩展知识：
RNA及缩氨酸医药的市场性与企业间的合作联盟
• 可参加探讨世界各国推行中的法规的未来进展、市场的展望、合作构想等主题的会议时段。

Keynote Presentations:

Synthesis and Biological Activity of the Nucleic Acids and Their Analogs
Marvin H. Caruthers, Ph.D., Distinguished Professor Chemistry and Biochemistry, University of Colorado, USA

Therapeutic Applications of Dicer Substrate siRNAs
John J. Rossi, Ph.D., Chairman, Lidow Family Endowed Research, Professor, Molecular Biology, Beckman Research Institute of City of Hope, USA
Presentation supported by Dicerna Pharmaceuticals

Defying Difficult Diseases: Biomolecule-based Medicinal Science
Yoshiaki Kiso, Ph.D., Professor & Chairman Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Japan

RNAi and Peptide Intellectual Property Landscapes: Early and Evolving
Kathleen M. Williams, Ph.D., J.D. Partner, Intellectual Property Law, Edwards Angell Palmer & Dodge LLP, USA